These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20496294)

  • 1. Advanced COPD: pathogenesis, evaluation, and treatment.
    Criner GJ; Celli BR
    Semin Respir Crit Care Med; 2010 Jun; 31(3):255. PubMed ID: 20496294
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic goals and outcome measurements in COPD patients].
    Morr H
    Med Klin (Munich); 2006 Apr; 101(4):279-82. PubMed ID: 16607483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adequate surrogate parameters in COPD studies].
    Cazzola M
    Dtsch Med Wochenschr; 2007 Mar; 132(10):522-3. PubMed ID: 17328003
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome.
    Roche N; Rabbat A; Zureik M; Huchon G
    Curr Opin Pulm Med; 2010 Mar; 16(2):112-7. PubMed ID: 20019614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No TWEAK for COPD.
    Lazaar AL; Miller BE; Francombe G; Duvoix A; Natanek SA; Polkey MI
    Eur Respir J; 2013 Oct; 42(4):1142-4. PubMed ID: 24081764
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction. COPD.
    Varkey B
    Curr Opin Pulm Med; 2009 Mar; 15(2):89. PubMed ID: 19225310
    [No Abstract]   [Full Text] [Related]  

  • 7. NIV treatment for acute exacerbation in COPD patients.
    Conti G; Costa R; Craba A; Tafani C; Iemma D; Pellegrini A; Morelli A
    Minerva Anestesiol; 2005 Jun; 71(6):249-53. PubMed ID: 15886584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New pharmacological options in the therapy of COPD].
    Watz H; Kanniess F; Magnussen H
    Pneumologie; 2007 Jun; 61(6):365-73. PubMed ID: 17492578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic obstructive pulmonary disease at the turn of the millennium].
    Marel M
    Cas Lek Cesk; 2002 Jun; 141(11):331-7. PubMed ID: 12099055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
    Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
    Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future perspectives in COPD.
    Celli B; Goldstein R; Jardim J; Knobil K
    Respir Med; 2005 Dec; 99 Suppl B():S41-8. PubMed ID: 16256325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential anti-inflammatory effect of exercise in chronic obstructive pulmonary disease.
    van der Vlist J; Janssen TW
    Respiration; 2010; 79(2):160-74. PubMed ID: 19672044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bronchodilatators and exercise in COPD: effects, evaluation and strategy of use].
    Perez T
    Rev Pneumol Clin; 2002 Sep; 58(4 Pt 2):2S11-7. PubMed ID: 12458313
    [No Abstract]   [Full Text] [Related]  

  • 16. The pathogenesis of COPD: lessons learned from in vivo animal models.
    Fujita M; Nakanishi Y
    Med Sci Monit; 2007 Feb; 13(2):RA19-24. PubMed ID: 17261992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD.
    Devanarayan V; Scholand MB; Hoidal J; Leppert MF; Crackower MA; O'Neill GP; Gervais FG
    COPD; 2010 Feb; 7(1):51-8. PubMed ID: 20214463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic obstructive pulmonary disease: from pathogenesis to treatment].
    Koczulla AR; Vogelmeier C
    Dtsch Med Wochenschr; 2008 Mar; 133(10):471-5. PubMed ID: 18302099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway responsiveness to indirect challenges in COPD.
    Hassan NM; Hargreave FE; Nair P
    COPD; 2010 Apr; 7(2):133-40. PubMed ID: 20397814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.